Pharmaceutical MDL-2848 Open - Limited • PAE

Zostavax Litigation

IN RE: Zostavax (Zoster Vaccine Live) Products Liability Litigation

826
Pending Actions
2,665
Total Actions Filed
69%
Resolution Rate
Active
Status
Updated 2026-05-01

Overview

The Zostavax Litigation is a federal multidistrict litigation consolidated in the PAE before Harvey Bartle, III (Sr. District Judge). This MDL involves claims related to pharmaceutical issues.

As of 2026-05-01, there are 826 pending actions out of 2,665 total actions filed, representing a 69% resolution rate.

Who May Qualify

Eligibility for this MDL typically depends on factors such as:

  • Documented exposure to or use of the product/device in question
  • Medical diagnosis of related injuries or conditions
  • Claim filed within the applicable statute of limitations

Key Information

Assigned Judge

Harvey Bartle, III (Sr. District Judge)

District Court

PAE

MDL Number

MDL-2848

Category

Pharmaceutical

Attorney Advertising. The information on this page is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this content. Results in MDL cases vary widely; past results do not guarantee future outcomes. If you believe you have a legal claim, consult a licensed attorney in your jurisdiction.